Chemokines and HIV-1 second receptors: The therapeutic connection (Q43938781)

28 November 2017

title

Chemokines and HIV-1 second receptors: the therapeutic connection (English)

1 reference

28 November 2017

Chemokines and HIV-1 second receptors: The therapeutic connection (English)

1 reference

chemokine receptor family

21 December 2024

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9585229

21 December 2024

HIV receptors

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9585229

21 December 2024

author name string

J. S. Cairns

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9585229

21 December 2024

M. P. D'Souza

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9585229

21 December 2024

publication date

1 May 1998

1 reference

28 November 2017

May 1998

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9585229

http://www.nature.com/articles/nm0598-563

21 December 2024

language of work or name

English

0 references

work available at URL

1 reference

http://www.nature.com/articles/nm0598-563.pdf

21 December 2024

1 reference

21 December 2024

1 reference

28 November 2017

volume

4

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

563-568

1 reference

publication type of scholarly work

28 November 2017

review article

1 reference

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

Identification of a major co-receptor for primary isolates of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

A new classification for HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 5'-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

Coreceptors--Implications for HIV Pathogenesis and Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

A phase I/IIA clinical study with a chimeric mouse-human monoclonal antibody to the V3 loop of human immunodeficiency virus type 1 gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

CD4-independent infection by HIV-2 is mediated by fusin/CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

Construction of a Novel Virus That Targets HIV-1-Infected Cells and Controls HIV-1 Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

Targeting of HIV- and SIV-Infected Cells by CD4-Chemokine Receptor Pseudotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

Harnessing Viral Devices as Pharmaceuticals: Fighting HIV-1's Fire with Fire

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

Identification of CCR8: a human monocyte and thymus receptor for the CC chemokine I-309

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

Inhibition of HIV-1 Infection by the β-Chemokine MDC

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

A Small Molecule CXCR4 Inhibitor that Blocks T Cell Line–tropic HIV-1 Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

A Small-molecule Inhibitor Directed against the Chemokine Receptor CXCR4 Prevents its Use as an HIV-1 Coreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

Expression cloning of new receptors used by simian and human immunodeficiency viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

A new SIV co-receptor, STRL33

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

Two Orphan Seven-Transmembrane Segment Receptors Which Are Expressed in CD4-positive Cells Support Simian Immunodeficiency Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

A new class of membrane-bound chemokine with a CX3C motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

A CXCR4/CD4 Pseudotype Rhabdovirus That Selectively Infects HIV-1 Envelope Protein-Expressing Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

HIV blocked by chemokine antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

HIV-1 subtype and second-receptor use

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

Chemokines and HIV-1 second receptors. Confluence of two fields generates optimism in AIDS research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239.

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

Intra- and extracellular immunization against HIV-1 infection with lymphocytes transduced with an AAV vector expressing a human anti-gp120 antibody

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

Ribozymes as potential anti-HIV-1 therapeutic agents

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

Chemokines and HIV replication

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

Genotypic and phenotypic characterization of HIV-1 patients with primary infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

HIV type 1 coreceptors, neutralization serotypes, and vaccine development

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-563

7 January 2021

Potent inhibition of human immunodeficiency virus type 1 in primary T cells and alveolar macrophages by a combination anti-Rev strategy delivered in an adeno-associated virus vector

29

1 reference

Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population

21 December 2024

61

1 reference

Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses

21 December 2024

67

1 reference

Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses

21 December 2024

74

1 reference

21 December 2024

Identifiers

DOI

10.1038/NM0598-563

1 reference

28 November 2017

1 reference